Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Grunow

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 9, 2019
Molecular identification of the source of an uncommon tularaemia outbreak, Germany, autumn 2016Daniela Jacob, Kristin Köppen, Aleksandar Radonić, et al.
Frontiers in Public Health|November 27, 2014
Benefits of a European project on diagnostics of highly pathogenic agents and assessment of potential "dual use" issuesRoland Grunow, G Ippolito, D Jacob, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 8, 2008
Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemiaMeliha Meric, Ayse Willke, Enrst-Jurgen Finke, et al.
Clinical and Vaccine Immunology : CVI|October 2, 2009
Development of antibodies against anthrose tetrasaccharide for specific detection of Bacillus anthracis sporesAndrea Kuehn, Pavol Kovác, Rina Saksena, et al.
Analytical Chemistry|September 28, 2010
Characterization of Yersinia using MALDI-TOF mass spectrometry and chemometricsPeter Lasch, Michal Drevinek, Herbert Nattermann, et al.
BMC Microbiology|June 26, 2014
Genome sequence and phenotypic analysis of a first German Francisella sp. isolate (W12-1067) not belonging to the species Francisella tularensisKerstin Rydzewski, Tino Schulz, Elzbieta Brzuszkiewicz, et al.
Analytical Chemistry|February 23, 2008
MALDI-TOF mass spectrometry compatible inactivation method for highly pathogenic microbial cells and sporesPeter Lasch, Herbert Nattermann, Marcel Erhard, et al.
Advances in Experimental Medicine and Biology|December 30, 2016
Prioritization of High Consequence Viruses to Improve European Laboratory Preparedness for Cross-Border Health ThreatsCarla Nisii, Roland Grunow, Andreas Brave, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 11, 2020
Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017Sandra Appelt, Daniela Jacob, Anna-Maria Rohleder, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 17, 2018
Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNetChantal B Reusken, Ramona Mögling, Pieter W Smit, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 9, 2019
Molecular identification of the source of an uncommon tularaemia outbreak, Germany, autumn 2016Daniela Jacob, Kristin Köppen, Aleksandar Radonić, et al.
Frontiers in Public Health|November 27, 2014
Benefits of a European project on diagnostics of highly pathogenic agents and assessment of potential "dual use" issuesRoland Grunow, G Ippolito, D Jacob, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 8, 2008
Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemiaMeliha Meric, Ayse Willke, Enrst-Jurgen Finke, et al.
Clinical and Vaccine Immunology : CVI|October 2, 2009
Development of antibodies against anthrose tetrasaccharide for specific detection of Bacillus anthracis sporesAndrea Kuehn, Pavol Kovác, Rina Saksena, et al.
Analytical Chemistry|September 28, 2010
Characterization of Yersinia using MALDI-TOF mass spectrometry and chemometricsPeter Lasch, Michal Drevinek, Herbert Nattermann, et al.
BMC Microbiology|June 26, 2014
Genome sequence and phenotypic analysis of a first German Francisella sp. isolate (W12-1067) not belonging to the species Francisella tularensisKerstin Rydzewski, Tino Schulz, Elzbieta Brzuszkiewicz, et al.
Analytical Chemistry|February 23, 2008
MALDI-TOF mass spectrometry compatible inactivation method for highly pathogenic microbial cells and sporesPeter Lasch, Herbert Nattermann, Marcel Erhard, et al.
Advances in Experimental Medicine and Biology|December 30, 2016
Prioritization of High Consequence Viruses to Improve European Laboratory Preparedness for Cross-Border Health ThreatsCarla Nisii, Roland Grunow, Andreas Brave, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 11, 2020
Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017Sandra Appelt, Daniela Jacob, Anna-Maria Rohleder, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 17, 2018
Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNetChantal B Reusken, Ramona Mögling, Pieter W Smit, et al.
Pageof 7